Sun Pharma to Acquire US-Based Checkpoint TherapeuticsÂ
India’s leading pharmaceutical company, Sun Pharmaceutical Industries, has announced the acquisition of Checkpoint Therapeutics, a U.S.-based biotechnology firm specialising in oncology. The deal is set to expand Sun Pharma’s oncology portfolio and strengthen its global presence in the rapidly growing cancer treatment market. Last year, the company signed a licensing agreement with Italian-Swiss firm Philogen…
Abdullah Ansari
Foreign Attempts to Control 76% of Haldiram’s Legacy
According to the reports, Blackstone, a leading private equity firm, along with Abu Dhabi Investment Authority (ADIA) and Singapore’s GIC, has put forward a non-binding offer to acquire a 76% stake in Haldiram for $8.5 billion. Haldiram is an 87-year-old renowned food, sweet, and snack chain established in Bikaner, Rajasthan, in 1937. The food chain…
Vipin